View in EDS HTML Full Text PDF Full Text

Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy.
Authors: Chueh, Chen-Han1 (AUTHOR), Tsai, Yi-Wen1 (AUTHOR) ywtsai@nycu.edu.tw, Chen, Zi-Rong1 (AUTHOR), Shiu, Ming-Neng1,2 (AUTHOR), Wen, Yu-Wen3 (AUTHOR), Chiang, Nai-Jung4,5 (AUTHOR) njchiang@vghtpe.gov.tw
Source: PharmacoEconomics. Mar2023, Vol. 41 Issue 3, p307-319. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 161884394
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Chueh%2C+Chen-Han%22">Chueh, Chen-Han</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tsai%2C+Yi-Wen%22">Tsai, Yi-Wen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> ywtsai@nycu.edu.tw</i><br /><searchLink fieldCode="AR" term="%22Chen%2C+Zi-Rong%22">Chen, Zi-Rong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shiu%2C+Ming-Neng%22">Shiu, Ming-Neng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wen%2C+Yu-Wen%22">Wen, Yu-Wen</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chiang%2C+Nai-Jung%22">Chiang, Nai-Jung</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<i> njchiang@vghtpe.gov.tw</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PharmacoEconomics%22">PharmacoEconomics</searchLink>. Mar2023, Vol. 41 Issue 3, p307-319. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=161884394
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40273-022-01227-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 307
    Titles:
      – TitleFull: Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chueh, Chen-Han
      – PersonEntity:
          Name:
            NameFull: Tsai, Yi-Wen
      – PersonEntity:
          Name:
            NameFull: Chen, Zi-Rong
      – PersonEntity:
          Name:
            NameFull: Shiu, Ming-Neng
      – PersonEntity:
          Name:
            NameFull: Wen, Yu-Wen
      – PersonEntity:
          Name:
            NameFull: Chiang, Nai-Jung
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 11707690
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: PharmacoEconomics
              Type: main
ResultId 1